1249781-69-8 Usage
Uses
Used in Pharmaceutical Industry:
6-Ethoxy-5-methylpyridin-3-amine is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, potentially offering novel therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, 6-Ethoxy-5-methylpyridin-3-amine serves as an essential component in the production of certain agricultural products. Its chemical properties make it suitable for use in the formulation of pesticides, herbicides, and other agrochemicals, contributing to enhanced crop protection and yield.
As a Chemical Intermediate:
6-Ethoxy-5-methylpyridin-3-amine is used as a valuable intermediate in the chemical synthesis process. Its versatile structure allows for further functionalization and modification, enabling the creation of a wide range of chemical compounds with diverse applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1249781-69-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,9,7,8 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1249781-69:
(9*1)+(8*2)+(7*4)+(6*9)+(5*7)+(4*8)+(3*1)+(2*6)+(1*9)=198
198 % 10 = 8
So 1249781-69-8 is a valid CAS Registry Number.
1249781-69-8Relevant articles and documents
NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF
-
Paragraph 0856; 0859; 1140; 1142, (2018/09/08)
An object of the present invention is to provide to a compound and a pharmaceutical composition, which have excellent Syk-inhibitory activity. Th e present invention provides a nicotinamide derivative represented by the follo wing formula (I) (wherein R 1 represents a halogen atom; R 2 represents a C 1-12 alkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, a C 3-8 cycloalkyl g roup, an aryl group, an ar-C 1-6 alkyl group or a heterocyclic group, each opti onally having at least one substituent; R 3 represents an aryl group or a hetero cyclic group each optionally having at least one substituent; and R 4 and R 5 e ach independently represent a hydrogen atom; and R 2 and R 4 may form a cyc lic amino group optionally having at least one substituent together with the ni trogen atom to which they bind) or a salt thereof, and a pharmaceutical comp osition for use in the treatment of a Syk-related disease which comprises the nicotinamide derivative or a salt thereof.
